H.I.G. Capital Expands Its Reach in Healthcare and Beyond
H.I.G. Capital, a prominent global investment firm, continues to reinforce its foothold in the healthcare sector and related industries through a series of strategic decisions. With $65 billion in assets under management, the firm seeks to harness growth opportunities in burgeoning markets by diversifying its portfolio.
A pivotal move for H.I.G. Capital was the acquisition of SkinCure Oncology, a leader in image-guided superficial radiation therapy (IG-SRT) for treating nonmelanoma skin cancer. This acquisition not only underscores the firm’s commitment to advancing innovative healthcare solutions but also positions it at the forefront of non-invasive cancer treatment technologies. SkinCure, with its GentleCure™ platform, has already partnered with over 500 physicians nationwide, showcasing its expansive reach and impact.
In a contrasting move, H.I.G. Capital recently sold BIOVECTRA, a company specializing in the development and manufacturing of active pharmaceutical ingredients. The sale to Agilent Technologies for $925 million marks a successful exit for H.I.G., which had previously helped BIOVECTRA expand its facilities and grow its commercial focus.
In addition to healthcare, H.I.G. Capital is broadening its horizons into the organic and natural products sector. The investment in Naturalia Tantum S.p.A. represents this shift, with the Italian company renowned for its organic beauty and personal care products. This acquisition aligns with the increasing consumer demand for natural and sustainable options.
Moreover, H.I.G. Capital’s interest in healthcare infrastructure was evident with its purchase of Action Elevator. By acquiring a company that specializes in elevator maintenance and modernization, the firm is investing in critical services that support healthcare facilities and other sectors.
Through these diverse investments, H.I.G. Capital demonstrates its strategy to engage with dynamic industries poised for significant growth and transformation.